TABLE 1

Injected Doses and Mass (Minimum–Maximum) for Radioligands and Respective Targets in Human Studies

RadioligandRadioligand targetInjected dose (MBq)Injected mass (μg)
11C-(+)-PHNOD2/D3 receptors209–3511.63–2.30
11C-FLB457D2/D3 receptors326–3440.59–0.60
11C-racloprideD2/D3 receptors272–3460.45–3.27
11C-DASBSerotonin transporter166–3590.25–0.61
11C-AS247190711β-HSD1 enzyme inhibitor208–2142.75–3.00
11C-UCB-JSynaptic vesicle protein 2A46–3221.00–1.49
  • Two subjects (1 male/1 female) were scanned for each radioligand with exception of 11C-(+)-PHNO (n = 4).